Search

everythinglearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Acitretin effectively treats severe hypertrophic lichen planus.

Nilotinib can cause keratosis pilaris, a skin condition.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Both topiramate and divalproex sodium effectively reduce migraine frequency and are generally well-tolerated.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Terbinafine HCl nail solutions with DDAIP HCl are more effective than current treatments for nail infections.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Tofacitinib helped a woman regrow hair with no major side effects.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

IPL treatment can significantly reduce hair in faun tail but may need local anesthesia.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Spanlastics improve drug delivery by enhancing bioavailability and targeting, reducing side effects.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Topical tacrolimus effectively treated scalp lesions, reversed skin atrophy, and promoted hair growth.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Combining low-level laser therapy with topical corticosteroids effectively improved Lichen Planopilaris symptoms.